Bridges M&C

Bridges M&C is a public relations and communications agency headquartered in Singapore, with a second office in Malaysia established in 2014. Founded in 2005, the firm has spent nearly two decades building a reputation for focused, high-quality work in the medical and healthcare sectors. The agency operates across the Asia-Pacific region, serving both B2B and consumer audiences. With a team of under 49 employees, Bridges M&C handles projects with budgets typically ranging from $25,000 to $50,000, and has been recognized for its professionalism, earning finalist positions in the PRAwards 2023 for Best PR Campaigns in both B2B and Healthcare & Pharmaceuticals categories. Notable clients include Bayer, Pfizer, and Johnson & Johnson.

Specialization in Medical and Healthcare Communications

Bridges M&C focuses exclusively on the medical and healthcare industries, a niche that demands deep subject matter expertise and sensitivity to regulatory environments. The agency covers a wide range of therapeutic areas, including oncology, dermatology, cardiology, ophthalmology, diabetes, medical aesthetics, and mental health. It also works extensively with medical devices, medtech, healthtech, and pharmaceutical companies. This specialization allows Bridges M&C to craft highly tailored communications strategies that resonate with healthcare professionals, patients, and policymakers alike. The agency’s work often involves disease awareness campaigns, public education programmes, and professional roundtables, all designed to elevate understanding and engagement around complex medical topics.

Services Tailored to the Healthcare Sector

The agency provides a comprehensive suite of public relations and communications services, all adapted to the unique needs of the medical field. Key offerings include:

• Media relations and media training for healthcare executives and spokespeople
• Social media campaigns and content localization for healthcare brands
• White papers and medical industry white papers on topics such as cardiology and medical devices
• Disease awareness and patient advocacy initiatives
• Public affairs and healthcare policy advocacy
• Medical event management, including professional roundtables and continued medical education
• Healthcare content localization to adapt global campaigns for Asia-Pacific markets
• Medical PR awards submissions and recognition programs

This service list reflects Bridges M&C’s ability to handle everything from high-level policy work to grassroots patient outreach. The agency’s experience in medical aesthetics and aesthetic medicine further demonstrates its versatility within the broader healthcare communications landscape.

Methodology and Approach

Bridges M&C takes a structured, evidence-based approach to PR and communications. The agency emphasizes the importance of understanding the scientific and regulatory context of each client’s work. For example, when developing a disease awareness campaign for a pharmaceutical client, the team conducts thorough research into the condition, its prevalence, and the patient journey. This informs the creation of targeted messaging that can be deployed across media relations, social media, and public education programmes. The agency also prioritizes measurement and evaluation, using metrics such as media impressions, engagement rates, and policy outcomes to demonstrate impact. Bridges M&C’s methodology is particularly well-suited to the medical sector, where accuracy and credibility are paramount.

Location and Regional Reach

Based at 176 Joo Chiat Rd, Singapore, 427447, Bridges M&C is strategically positioned in one of Asia’s most important business hubs. From Singapore, the agency serves clients across the Asia-Pacific region, leveraging local market knowledge and relationships to execute campaigns that are culturally relevant and compliant with local regulations. The additional office in Malaysia, opened in 2014, extends the agency’s reach into Southeast Asia, a region with rapidly growing healthcare markets. This dual-office structure allows Bridges M&C to offer seamless support for multinational clients while maintaining a strong local presence in key markets.

Bridges M&C is a strong fit for pharmaceutical companies, medical device manufacturers, healthtech startups, and medical aesthetics brands looking for a specialized PR partner in the Asia-Pacific region. The agency’s deep expertise in medical communications, combined with its track record of award-nominated campaigns, makes it a reliable choice for organizations that need nuanced, compliant, and effective public relations support. Whether the goal is to raise disease awareness, manage a product launch, or shape healthcare policy, Bridges M&C offers the focused experience to deliver results.